Balyasny Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$340K Sell
1,800
-6,600
-79% -$1.39M ﹤0.01% 2515
2025
Q4
$1.67M Buy
8,400
+7,200
+600% +$1.46M ﹤0.01% 1957
2025
Q3
$244K Buy
+1,200
New +$213K ﹤0.01% 2656
2020
Q2
Sell
-200,000
Closed -$2.88M 1480
2020
Q1
$2.88M Buy
+200,000
New +$5.74M 0.03% 526
2014
Q3
Sell
-200,000
Closed -$9.39M 855
2014
Q2
$9.39M Buy
+200,000
New +$9.04M 0.11% 245

Other funds holding THC

Balyasny Asset Management's THC Position: Q1 2026 in Review

Balyasny Asset Management reduced its Tenet Healthcare (THC) stake by 99% in Q1 2026, selling an estimated $30M and leaving 1,163 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

Balyasny Asset Management first reported a position in THC in Q2 2013 and has held it in 38 quarters since. The position peaked at $70.3M in Q3 2025. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Balyasny Asset Management held 1,163 shares of Tenet Healthcare worth $219K as of Q1 2026.
  • Balyasny Asset Management sold 142,551 Tenet Healthcare shares in Q1 2026, an estimated $30M.
  • Tenet Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2667 holding.
  • Balyasny Asset Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 38 quarters since.
  • Balyasny Asset Management's Tenet Healthcare position peaked at $70.3M in Q3 2025.
  • 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.